Effects of Oral Levosimendan (ODM-109) on Respiratory Function in Patients With ALS
Condition: Amyotrophic Lateral Sclerosis Interventions: Drug: Levosimendan; Drug: Placebo for levosimendan Sponsor: Orion Corporation, Orion Pharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials